Biogen Inc. (BIIB)
USD 146.79
(-2.56%)
USD 146.79
(-2.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.54 Billion | 1.38 Billion | 3.63 Billion | 4.22 Billion | 7.07 Billion | 6.18 Billion |
| Net Income | 1.16 Billion | 2.96 Billion | 1.72 Billion | 4.06 Billion | 5.88 Billion | 4.47 Billion |
| Depreciation & Amortization | 494.8 Million | 518.4 Million | 487.7 Million | 457.2 Million | 680.6 Million | 1.01 Billion |
| Deferred income taxes | -305.8 Million | -168.6 Million | -426.8 Million | 149 Million | 67.1 Million | 108.3 Million |
| Stock-based compensation | 264.2 Million | 254.1 Million | 238.6 Million | 198.3 Million | 182.3 Million | 157.5 Million |
| Change in working capital | -648.7 Million | -890.3 Million | -145.5 Million | -187.2 Million | 199.3 Million | 400.2 Million |
| Other non-cash items | 581.2 Million | -1.29 Billion | 1.75 Billion | -448 Million | 60.8 Million | 31.1 Million |
| Investing Cash Flow | -4.1 Billion | 1.57 Billion | -563.7 Million | -608.6 Million | 470.5 Million | -2.04 Billion |
| Investments in PPE | -311.4 Million | -243.2 Million | -294.9 Million | -551.8 Million | -669.5 Million | -886.1 Million |
| Acquisitions | -6.13 Billion | 990.3 Million | 28.1 Million | -565.5 Million | -120.7 Million | -2.17 Billion |
| Investment purchases | -5.14 Billion | -3.44 Billion | -3.8 Billion | -6.83 Billion | -5.25 Billion | -8.15 Billion |
| Sales/Maturities of investments | 7.5 Billion | 3.67 Billion | 3.49 Billion | 7.37 Billion | 6.48 Billion | 9.17 Billion |
| Other Investing Activities | -11.3 Million | 607 Million | 12.9 Million | -26.9 Million | 27 Million | 400 Thousand |
| Financing Cash Flow | 149.3 Million | -1.75 Billion | -2.08 Billion | -5.27 Billion | -5.86 Billion | -4.47 Billion |
| Debt repayment | -809.9 Million | -1 Billion | -170 Million | -1.5 Billion | - | -3.2 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -750 Million | -1.8 Billion | -6.67 Billion | -5.86 Billion | -4.35 Billion |
| Common Stock Issuance | -44.3 Million | -1.9 Million | -700 Thousand | -4.6 Million | - | -2.1 Million |
| Other Financing Activities | 6.3 Million | -5.6 Million | -115.5 Million | -56.4 Million | 7.9 Million | -114.1 Million |
| Accounts receivables | 61.3 Million | -203.4 Million | 324.8 Million | 2.8 Million | 68.8 Million | -205.2 Million |
| Accounts payables | -206.2 Million | - | -94.2 Million | 330.9 Million | 133.6 Million | 335.8 Million |
| Inventory | -130.9 Million | -320.2 Million | -462.4 Million | -316.3 Million | -19.2 Million | -52.1 Million |
| Other working capital | -372.9 Million | -366.7 Million | 86.3 Million | -204.6 Million | 16.1 Million | 321.7 Million |
| Cash at beginning of period | 3.41 Billion | 2.26 Billion | 1.33 Billion | 2.91 Billion | 1.22 Billion | 1.57 Billion |
| Cash at end of period | 1.04 Billion | 3.41 Billion | 2.26 Billion | 1.33 Billion | 2.91 Billion | 1.22 Billion |
| Capital Expenditure | -311.4 Million | -243.2 Million | -294.9 Million | -551.8 Million | -669.5 Million | -886.1 Million |
| Effect of forex changes on cash | 35.1 Million | -55.7 Million | -59.8 Million | 69 Million | 400 Thousand | -18.6 Million |
| Net cash flow / Change in cash | -2.36 Billion | 1.15 Billion | 930.2 Million | -1.58 Billion | 1.68 Billion | -349.2 Million |
| Free Cash Flow | 1.23 Billion | 1.14 Billion | 3.34 Billion | 3.67 Billion | 6.4 Billion | 5.3 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -977 Million | 583.6 Million | 393.4 Million | 248.9 Million | 1.16 Billion | -68.3 Million |
| Depreciation & Amortization | -306.4 Million | 158.8 Million | 147.6 Million | 140.1 Million | 494.8 Million | 125 Million |
| Deferred income taxes | 47.1 Million | -87 Million | 39.9 Million | 71.9 Million | -305.8 Million | -206.8 Million |
| Stock-based compensation | -143.4 Million | 70.6 Million | 72.8 Million | 54.9 Million | 264.2 Million | 62.2 Million |
| Change in working capital | 417.3 Million | -188.6 Million | -228.7 Million | -648.1 Million | -648.7 Million | 314.4 Million |
| Other non-cash items | 1.89 Billion | 674.3 Million | 489.5 Million | 144.8 Million | 581.2 Million | 365.9 Million |
| Investing Cash Flow | -1.18 Billion | 466.5 Million | -66 Million | -652.3 Million | -4.1 Billion | -1.74 Billion |
| Investments in PPE | 277.9 Million | -42.6 Million | -120.9 Million | -65.2 Million | -311.4 Million | -87.6 Million |
| Acquisitions | -1.07 Billion | - | - | -590.5 Million | -6.13 Billion | -6.33 Billion |
| Investment purchases | - | - | - | - | -5.14 Billion | -1.02 Billion |
| Sales/Maturities of investments | -567.3 Million | 511.7 Million | 55.6 Million | 13.4 Million | 7.5 Billion | 5.7 Billion |
| Other Investing Activities | -891.7 Million | -2.6 Million | -700 Thousand | -10 Million | -11.3 Million | -200 Thousand |
| Financing Cash Flow | -6.6 Million | -245.2 Million | -439.6 Million | -646.1 Million | 149.3 Million | 848.6 Million |
| Debt repayment | -650 Million | -250 Million | -400 Million | -650 Million | -809.9 Million | -837.3 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -9.3 Million | 9.3 Million | - | - | - | - |
| Common Stock Issuance | 40.8 Million | 6.1 Million | -46.9 Million | 3.7 Million | -44.3 Million | 6.6 Million |
| Other Financing Activities | 611.9 Million | -1.3 Million | 7.3 Million | 200 Thousand | 6.3 Million | 4.7 Million |
| Accounts receivables | 2.8 Million | -87.2 Million | 84.4 Million | 137.8 Million | 61.3 Million | -98.3 Million |
| Accounts payables | - | - | - | -503.2 Million | -206.2 Million | 430.8 Million |
| Inventory | 188.2 Million | -110.5 Million | -77.7 Million | -96 Million | -130.9 Million | 30.2 Million |
| Other working capital | 226.3 Million | 9.1 Million | -235.4 Million | -186.7 Million | -372.9 Million | -48.3 Million |
| Cash at beginning of period | 1.9 Billion | 1.07 Billion | 1.04 Billion | 2.28 Billion | 3.41 Billion | 2.61 Billion |
| Cash at end of period | 1.69 Billion | 1.9 Billion | 1.07 Billion | 1.04 Billion | 1.04 Billion | 2.28 Billion |
| Capital Expenditure | 277.9 Million | -42.6 Million | -120.9 Million | -65.2 Million | -311.4 Million | -87.6 Million |
| Effect of forex changes on cash | 35.7 Million | -12.6 Million | -23.1 Million | 47.9 Million | 35.1 Million | -28.7 Million |
| Net cash flow / Change in cash | -216.4 Million | 834.5 Million | 24.5 Million | -1.23 Billion | -2.36 Billion | -329.9 Million |
| Free Cash Flow | 1.21 Billion | 583.2 Million | 432.3 Million | -52.7 Million | 1.23 Billion | 504.8 Million |
CTXDF
CLARA
0QON
TCNNF
PRDO
GPPRF